Publications by authors named "Layla Pagnucco"

Claim this Profile
T
Time fixes everything, but not always: 10 years of persistent PI mutations in the absence of pharmacological pressure-a case report.
Layla Pagnucco, Antonella Castagna, Maria Mercedes Santoro, Maurizio Zazzi, Vincenzo Spagnuolo

J Antimicrob Chemother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study).
Diego Ripamonti, Laura Comi, Andrea Francavilla, Daniela Valenti, Maria Vittoria Cossu, Layla Pagnucco

J Antimicrob Chemother· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients.
Franco Maggiolo, Roberto Gulminetti, Layla Pagnucco, Margherita Digaetano, Adriana Cervo

BMC Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing?
Andrea Lombardi, Marta Colaneri, Kesav Aditya Vijayagopal, Margherita Sambo, Patrizia Legnazzi, Layla Pagnucco

Dig Liver Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A challenging case of SARS-CoV-2- AIDS and Nocardiosis coinfection from the SMatteo COvid19 REgistry (SMACORE).
Marta Colaneri, Matteo Lupi, Michele Sachs, Serena Ludovisi, Angela Di Matteo, Layla Pagnucco

New Microbiol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Weight Gain in People Treated With Dolutegravir.
Lucia Taramasso, Paolo Bonfanti, Elena Ricci, Giancarlo Orofino, Nicola Squillace, Layla Pagnucco

Open Forum Infect Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort.
Alessandro Soria, Marco Fava, Davide P Bernasconi, Giuseppe Lapadula, Elisa Colella, Layla Pagnucco

Liver Int· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020.
Marta Colaneri, Paolo Sacchi, Valentina Zuccaro, Simona Biscarini, Michele Sachs, Layla Pagnucco

Euro Surveill· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients.
Franco Maggiolo, Roberto Gulminetti, Layla Pagnucco, Margherita Digaetano, Simone Benatti

BMC Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis